Stay up to date with the latest Hims & Hers Health, Inc. stock price movements on Seeking Alpha's interactive chart. View comprehensive price data and historical prices on HIMS here.
Hims & Hers Health期权聚焦:11月27日成交11.33万张,未平仓合约58.74万张 富途资讯11/28 05:30 聚焦Hims和hers健康:分析期权活动的激增 资深投资者对Hims & Hers Health (纽交所:HIMS) 采取了看好的态度,这是市场参与者不应忽视的事情。我们在Benzinga跟踪了公开期权记录 Benzinga11/28 04:36 ...
View Hims & Hers Health (HIMS) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Trade commission-free with the Futubull stock trading app.
Check out the latest Hims & Hers Health (HIMS) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.
A high-level overview of Hims & Hers Health, Inc. (HIMS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
【美国健康科技企业Hims & Hers Health盘前交易剧烈下挫2.73%,股价定位于17.08美元。】 在5月20日,据美国证券交易委员会文件发布,Hims & Hers Health公司的普通股遭遇Boughton Soleil抛售,共计4,915股,平均出售价格为每股20.0148美元,此次交易总额接近9.84万美元。
HIMS | Complete Hims & Hers Health Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
5月21日,Hims&Hers Health(HIMS.US)美股盘前股价延续昨日大涨态势,涨幅达到3.55%,最新报价为19.26美元。 公司今日宣布重磅消息,将推出新型司美格鲁肽复合药物,定价每月仅需199美元。与之相比,市面上同类产品,例如诺和诺德Wegovy的月费用高达1350美元以上,而诺和泰价目也在900美元以上,Hims&Hers Health定价优势显著,至...
Get the latest Hims & Hers Health Inc. Class A (HIMS) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Financial Health Valuation Podcast Episodes Related Stocks Podcast Episodes A New Name in Weight Loss Drugs Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option. ...